Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 3, 2005
May 5, 2020
2c9aed18-87e7-4700-8c3b-593f58e268e8
Related Documents
Exposure-Response Relationships — Study Design, Data Analysis, and Regulatory Applications
Guidance DocumentMay 5, 2003Center for Drug Evaluation and Research
Q1E Evaluation of Stability Data
Guidance DocumentJune 8, 2004Center for Drug Evaluation and Research
E9 Statistical Principles for Clinical Trials
Guidance DocumentSeptember 16, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.